Metopirone

Metyrapone, the active ingredient in Metopirone, is a steroidogenesis inhibitor presented as an oral tablet for oral use. It blocks cortisol synthesis and is employed in the management of Cushing's syndrome and in diagnostic testing for adrenal insufficiency.

GNH USA supplies Metopirone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Customers benefit from reliable logistics, transparent documentation, and responsive technical support throughout the procurement process.

Metopirone acts on cortisol production pathways and is indicated for conditions related to excess or assessment of adrenal function.

- Cushing's syndrome: reduces cortisol levels to help control hypercortisolism in patients with endogenous disease. - Diagnostic testing for adrenal insufficiency: used to evaluate adrenal reserve by inhibiting cortisol synthesis during stimulation tests. - Research of steroidogenesis: employed as a pharmacological tool to study 11‑beta‑hydroxylase activity in clinical investigations.

Metopirone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Vomiting - Dizziness - Headache - Fatigue - Abdominal discomfort

Serious or Rare Side Effects: - Adrenal crisis due to abrupt cortisol deficiency - Severe hypotension - Allergic reactions such as rash or angioedema - Hepatic dysfunction - Hyponatremia or electrolyte disturbances - Hypoglycemia

When using Metopirone, clinicians should observe several precautionary measures to ensure patient safety.

- Monitor cortisol levels: regularly assess serum cortisol to guide therapy. - Adjust dose in hepatic impairment: reduce dosage if liver function is compromised. - Caution in hypertension: blood pressure may fluctuate; observe closely. - Avoid use in pregnancy unless essential: limited data on fetal safety. - Review electrolyte status: watch for sodium and potassium abnormalities. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Metopirone can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase metyrapone exposure. - Glucocorticoid therapy: concurrent steroids can counteract cortisol suppression. - Rifampicin: potent inducer that reduces metyrapone levels.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: blood pressure changes may require dose adjustment. - Antidiabetic drugs: altered cortisol may affect glucose control.